Literature DB >> 15659036

In vivo gene delivery of Ad-VEGF121 to full-thickness wounds in aged pigs results in high levels of VEGF expression but not in accelerated healing.

Jan J Vranckx1, Feng Yao, Nicola Petrie, Hanka Augustinova, Daniela Hoeller, Scott Visovatti, Jarek Slama, Elof Eriksson.   

Abstract

We have previously reported that endogenous vascular endothelial growth factor (VEGF) concentration in older pig wounds peaked later and at one-fourth the level of young pigs. These data suggested that VEGF might play a major role in the healing of full-thickness wounds in the aged pig. By in vivo gene transfer using the microseeding technique, we treated full-thickness wounds with different doses of VEGF-expressing adenoviral vector (Ad-VEGF) varying from 1 x 10(7) to 2.7 x 10(11) particles per wound (ppw). We found that the VEGF expression in wound fluid followed a dose-response pattern. However, when wounds were microseeded with the highest concentration of Ad-VEGF (2.7 x 10(11) ppw), diminished healing rates were found. We then determined the minimal functional concentrations of Ad-VEGF. We used five aged Yucatan minipigs, all retired breeders, to analyze the role of over-expression of 1 x 10(8) and 1 x 10(9) ppw of Ad-VEGF (n= 78) in terms of healing of full-thickness wounds, all 2.5 x 2.5 x 1 cm in size (n= 158). The Ad-VEGF solutions were delivered to the wound floor and borders by in vivo microseeding. Control wounds (n= 80) were microseeded with Ad-Lac-Z (n= 25), treated with saline (n= 49) or treated dry (n= 6). All wounds except for the dry-treated ones were covered with a wound chamber and a wet environment was created by injecting 2.5 ml saline into the chamber. Peak VEGF expression (2300-4000 pg/ml) was detected on days 2 or 3 post gene delivery. This level of VEGF expression was not seen in the saline (n= 49) or Ad-null (n= 25) control groups. The VEGF expression in wounds treated with 1 x 10(8) and 3 x 10(8) ppw (n= 39) exhibited a slower onset with a peak concentration of 400-920 pg/ml on days 5-7. Although high levels of VEGF expression were achieved in the local wound environment, we could not show a significant increase in neovascularization as compared to saline-treated wounds. No significant differences were observed in the rate of reepithelialization and wound contraction among groups of full-thickness wounds treated with Ad-VEGF, Ad-null mutant, or saline in the aged "wet wound healing" pig model. These results indicate that increased levels of VEGF in wounds produced by in vivo gene transfer have little effect on the healing of full-thickness wounds in the aged pig model. Moreover, significantly higher levels of VEGF expression by Ad-VEGF could lead to impaired wound healing.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15659036     DOI: 10.1111/j.1067-1927.2005.130107.x

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  12 in total

Review 1.  Acute and impaired wound healing: pathophysiology and current methods for drug delivery, part 2: role of growth factors in normal and pathological wound healing: therapeutic potential and methods of delivery.

Authors:  Tatiana N Demidova-Rice; Michael R Hamblin; Ira M Herman
Journal:  Adv Skin Wound Care       Date:  2012-08       Impact factor: 2.347

2.  Strategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal wounds.

Authors:  Alexander Stoff; Angel A Rivera; N S Banerjee; J Michael Mathis; Antonio Espinosa-de-los-Monteros; Long P Le; Jorge I De la Torre; Luis O Vasconez; Thomas R Broker; Dirk F Richter; Mariam A Stoff-Khalili; David T Curiel
Journal:  Wound Repair Regen       Date:  2006 Sep-Oct       Impact factor: 3.617

3.  Transgenic overexpression of keratinocyte-specific VEGF and Ang1 in combination promotes wound healing under nondiabetic but not diabetic conditions.

Authors:  Candace M Loyd; Doina Diaconu; Wen Fu; Gregory N Adams; Erin Brandt; Dorothy A Knutsen; Julie A Wolfram; Thomas S McCormick; Nicole L Ward
Journal:  Int J Clin Exp Pathol       Date:  2012-01-01

4.  A new technique of ex vivo gene delivery of VEGF to wounds using genetically modified skin particles promotes wound angiogenesis.

Authors:  Taro Koyama; Florian Hackl; Pejman Aflaki; Juri Bergmann; Baraa Zuhaili; Emily Waisbren; Usha Govindarajulu; Feng Yao; Elof Eriksson
Journal:  J Am Coll Surg       Date:  2011-01-17       Impact factor: 6.113

5.  Extracellular Vesicles from Adipose-Derived Stem Cells Promote Diabetic Wound Healing via the PI3K-AKT-mTOR-HIF-1α Signaling Pathway.

Authors:  Wenjian Liu; Yu Yuan; Dewu Liu
Journal:  Tissue Eng Regen Med       Date:  2021-09-20       Impact factor: 4.451

6.  Regulation of scar formation by vascular endothelial growth factor.

Authors:  Traci A Wilgus; Ahalia M Ferreira; Tatiana M Oberyszyn; Valerie K Bergdall; Luisa A Dipietro
Journal:  Lab Invest       Date:  2008-04-21       Impact factor: 5.662

Review 7.  Vascular Endothelial Growth Factor and Angiogenesis in the Regulation of Cutaneous Wound Repair.

Authors:  Kelly E Johnson; Traci A Wilgus
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-10-01       Impact factor: 4.730

8.  Arnebin-1 promotes angiogenesis by inducing eNOS, VEGF and HIF-1α expression through the PI3K-dependent pathway.

Authors:  Zhi Zeng; Wen-Dong Huang; Qi Gao; Mei-Ling Su; Yong-Fei Yang; Zhao-Chun Liu; Bang-Hao Zhu
Journal:  Int J Mol Med       Date:  2015-07-22       Impact factor: 4.101

9.  Microwave Saturation of Complex EPR Spectra and Free Radicals of Burnt Skin Treated with Apitherapeutic Agent.

Authors:  Pawel Olczyk; Pawel Ramos; Marcin Bernas; Katarzyna Komosinska-Vassev; Jerzy Stojko; Barbara Pilawa
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-27       Impact factor: 2.629

10.  Propolis induces chondroitin/dermatan sulphate and hyaluronic Acid accumulation in the skin of burned wound.

Authors:  Pawel Olczyk; Katarzyna Komosinska-Vassev; Katarzyna Winsz-Szczotka; Jerzy Stojko; Katarzyna Klimek; Ewa M Kozma
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-07       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.